Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying & Areas That Are Now Pain ...
January 30 2012 - 10:29AM
Business Wire
Cannabis Science, Inc. (OTCBB:CBIS.OB) a pioneering U.S. biotech
company developing pharmaceutical cannabis (marijuana) products, is
pleased to share new photographs from this cancer patient with
severe squamous cell carcinoma. These pictures clearly show that
this patient, with previously treatment-resistant tumors, continues
to make obvious improvement. The tumors appear to be dying and then
healing after treatment with cannabis-based extracts.
Cannabis Science has been working closely with this patient who
has multiple squamous cell carcinoma tumors on his head. The latest
pictures indicate that this patient is making dramatic improvement
using cannabis-extract topical therapy under scientific guidance
from Cannabis Science.
In this pictorial sequence, you can see the tumors healing, and
scabbing over. The holes, like a “bowling ball finger hole”, are
now filled and scabbing over as healing appears to continue. In
another set of images, tumor mass continues to degrade. The patient
has also informed Cannabis Science that while using cannabis
extracts he has had a sufficient reduction in pain as healing
progresses.
Position A: The arrow in Figure 1 points to what was the
“bowling ball finger hole” that went down to the skull and was
obvious prior to any type treatment. Figure A2 shows that in just
the few days since our last update, the scabbed over hole has
filled in and is almost totally healed. This lesion is now totally
pain free.
Position B: The arrow in Figure B1, B2, and B3 point to an
orientation position. These three sequential photographs show the
tumor receding from this point as tumor mass continues to degrade.
A doctor who felt this tumor commented that it appears to be
detached and ready to fall off. Friends and family are amazed at
the rapid progress.
Position C: This tumor, after becoming open and bloody in photo
2, is now scabbed over and pain free in photo 3.
Cannabis Science works closely with numerous patients who are
suffering from a variety of illnesses and self-treating their
illnesses with cannabis extracts. With its global impact on so many
people and often-poor treatment outcomes for patients, we have
focused on cannabis extract-based treatment options for cancer.
Cannabis Science has provided the scientific foundation for
numerous patients suffering from cancer to make the informed
decision to treat themselves with cannabis extracts.
You can view these graphic photos on the Cannabis Science
website www.cannabisscience.com and click the button “View Images
of 3rd Self-Medicated Patient & His Apparent Success”.
You can read more news on this 3rd patient as well on the
Cannabis Science website www.cannabisscience.com and click on the
breaking news button where you will find all the cancer related and
updated patient news.
About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of pharmaceutical
grade medical marijuana research and development. The second
formulations will address the needs of patients choosing to use
concentrated cannabis extracts to treat their ailments. Eventually,
all Americans will have access to a safe and effective FDA approved
medicine regardless of which state they live in. To maintain that
marijuana is a dangerous, addictive drug with no medical value is
scientifically absurd. Cannabis medicines, with no effective lethal
dose, are far safer than aspirin, acetaminophen, and most other OTC
drugs that kill thousands of Americans every year.
The Company works with world authorities on phytocannabinoid
science targeting critical illnesses, and adheres to scientific
methodologies to develop, produce and commercialize
phytocannabinoid-based pharmaceutical products. In sum, we are
dedicated to the creation of cannabis-based medicines, both with
and without psychoactive properties, to treat disease and the
symptoms of disease, as well as for general health maintenance.
Forward Looking Statements
This Press Release includes forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Act of 1934. A statement containing
works such as "anticipate," "seek," intend," "believe," "plan,"
"estimate," "expect," "project," "plan," or similar phrases may be
deemed "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. Some or all of
the events or results anticipated by these forward-looking
statements may not occur. Factors that could cause or contribute to
such differences include the future U.S. and global economies, the
impact of competition, and the Company's reliance on existing
regulations regarding the use and development of cannabis-based
drugs. Cannabis Science, Inc. does not undertake any duty nor does
it intend to update the results of these forward-looking
statements.